Cargando…
Loss of treatment benefit due to low compliance with bisphosphonate therapy
SUMMARY: Among 8,822 new female bisphosphonate users, non-compliant bisphosphonate use was associated with a 45% increased risk of osteoporotic fracture compared to compliant use (MPR ≥80%). Classifying compliance into five categories, fracture risk gradually increased with poorer compliance. These...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267483/ https://www.ncbi.nlm.nih.gov/pubmed/17874028 http://dx.doi.org/10.1007/s00198-007-0466-1 |